Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Curex vs Optimized Health

Two GLP-1 desks, one scoreboard. We put Curex and Optimized Health head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 21 · Grade B

Curex

Visit Curex Full brief →

FDA warning letter, September 2025 — issued to Curex. See the FDA's warning letter database.

vs
No. 129 · Grade C

Optimized Health

Visit Optimized Health Full brief →

The verdict

Curex takes this head-to-head.

Curex scores 86 to 71 on our six-factor Brief Score — Identical $199 pricing on both molecules, an oral route, LegitScript-certified and nationwide.

That doesn't make Optimized Health a bad call — it's best for patients in mo/ia/ks/ut/wa wanting transparent, lab-guided compounded glp-1 weight loss. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
85
48
Supply Reliability
85
77
Transparency
87
88
Access Breadth
90
62
Clinical Oversight
86
76
Track Record
81
82
CurexBrief Score 86 · 71Optimized Health

Price, coverage & the tracker

CurexOptimized Health
Brief Score86/100 (B)71/100 (C)
Semaglutide$199/moFrom $200/mo (starting dose, compounded)
Tirzepatide$199/moFrom $250/mo (starting dose, compounded)
CoverageAll 50 states5 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
On the trackerStableprice stableNewnew to the tracker, no prior reading

Curex: Flat $199 on both molecules; LegitScript-certified and nationwide.

Optimized Health: New to the tracker on 1 August 2026. The published line reads From $200/mo (starting dose, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.